ArticleCancer chemotherapy and pharmacology2021

An investigation into possible interactions among four vascular epidermal growth factor receptor-tyrosine kinase inhibitors with gefitinib.

Chenxiang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.